Benzylamine-based selective and orally bioavailable inhibitors of thrombin
- 1 September 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (18) , 2563-2568
- https://doi.org/10.1016/s0960-894x(98)00456-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Discovery of LB30057, a benzamidrazone-based selective oral thrombin inhibitorBioorganic & Medicinal Chemistry Letters, 1998
- Design of Novel, Potent, Noncovalent Inhibitors of Thrombin with Nonbasic P-1 Substructures: Rapid Structure−Activity Studies by Solid-Phase SynthesisJournal of Medicinal Chemistry, 1998
- Chapter 6. Thrombin and Factor Xa InhibitionPublished by Elsevier ,1996
- Challenges in the development of orally bioavailable thrombin active site inhibitorsBlood Coagulation & Fibrinolysis, 1995
- Thrombin active site inhibitorsBioorganic & Medicinal Chemistry, 1995
- Thrombin inhibitors A new generation of antithromboticsTrends in Cardiovascular Medicine, 1995
- Argatroban analogs: Synthesis, thrombin inhibitory activity and cell permeability of aminoheterocyclic guanidine surrogatesBioorganic & Medicinal Chemistry Letters, 1994
- Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profileTrends in Pharmacological Sciences, 1993
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991
- Epithelial Transport Of Drugs In Cell Culture. I: A Model For Studying The Passive Diffusion Of Drugs Over Intestinal Absorbtive (Caco-2) CellsJournal of Pharmaceutical Sciences, 1990